We performed a univariate analysis of OS with several factors (including age, HSCT type, AML subtype, cytogenetic risk, HCT-CI, conditioning regimens, response to induction therapy, MRD on flow cytometry, and Flt3 mutation status). The gene discussed is FLT3; the disease is acute myeloid leukemia.